Advancing Heart Failure Treatment: The Role of Multipoint Pacing in Cardiac Resynchronization Therapy

Authors

  • Abdulmohsen Almusaad Departments King Abdulaziz Cardiac Center, King Abdulaziz Medical City, MNGHA, Riyadh, Saudi Arabia & King Abdullah International Medical Research Center (KAIMRC) Riyadh, Saudi Arabia
  • Ahmed Bander Alsalem Departments King Abdulaziz Cardiac Center, King Abdulaziz Medical City, MNGHA, Riyadh, Saudi Arabia
  • Muneera AlTaweel Department of Internal Medicine, King Abdulaziz Hospital, MNGHA Al-Ahsa, Saudi Arabia & King Abdullah International Medical Research Center (KAIMRC), Al-Ahsa, Saudi Arabia
  • Sarah AlMukhaylid College of Applied Medical Sciences (CoAMS-A), King Saud Bin Abdulaziz University for Health Sciences, Al-Ahsa, Saudi Arabia
  • Mazen AlRasheed Departments King Abdulaziz Cardiac Center, King Abdulaziz Medical City, MNGHA, Riyadh, Saudi Arabia
  • Yahya AlHebaishi Prince Sultan Cardiac Center, Riyadh, Kingdom of Saudi Arabia
  • Haitham Alanazi Departments King Abdulaziz Cardiac Center, King Abdulaziz Medical City, MNGHA, Riyadh, Saudi Arabia

DOI:

https://doi.org/10.55677/IJCSMR/V4I11-02/2024

Keywords:

Cardiac resynchronization therapy, Multipoint pacing, heart failure, dyssynchrony

Abstract

Cardiac resynchronization therapy (CRT) with biventricular pacing is a standard therapy for patients with heart failure, reduced ejection fraction, and electrical dyssynchrony. However, approximately 30% of patients do not respond to CRT. Multipoint pacing (MPP) has emerged as an innovative strategy that paces multiple left ventricular sites to achieve more comprehensive resynchronization. This review explores the evolution of MPP, including the underlying scientific rationale, clinical evidence from key trials, technological considerations of quadripolar leads and programmability, patient selection criteria, optimization strategies, and future directions. Early feasibility studies demonstrated acute hemodynamic improvements with MPP. Larger trials have shown superior outcomes with MPP compared to conventional biventricular pacing, including increased CRT response rates, reduced hospitalizations, and improved ejection fraction and reverse remodeling. However, recent multicenter trials found no significant differences between the population's MPP and biventricular pacing. Ongoing research aims to refine patient selection for MPP and optimize lead positioning and programming configurations to maximize benefits. As technological capabilities expand, MPP promises to provide tailored, physiological pacing therapies that may enhance outcomes for heart failure patients requiring CRT. This comprehensive review examines the various aspects of MPP, including its scientific foundation, clinical evidence, technological considerations, impact on patient quality of life, and future implications. By critically assessing the current literature and identifying gaps in knowledge, we aim to provide a thorough understanding of MPP’s role in the evolving landscape of heart failure management.

References

Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;15: 1539-1549

Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W; MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;14: 1329-1338.

Moskovitch J, Voskoboinik A. Cardiac resynchronization therapy: a comprehensive review. Minerva Med 2018;110.2: 121-138

Sieniewicz BJ, Gould J, Porter B, Sidhu BS, Teall T, Webb J, Carr-White G, Rinaldi CA. Understanding non-response to cardiac resynchronisation therapy: common problems and potential solutions. Heart Fail Rev 2019; 24: 41-54

Wang Y, Sharbaugh MS, Munir MB, Adelstein EC, Wang NC, Althouse AD, Saba S. Gender Differences in Cardiac Resynchronization Therapy Device Choice and Outcome in Patients ≥75 Years of Age with Heart Failure. Am J Cardiol 2017;12: 2201-2206

Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008 2008;21: e350-e408

Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC; Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;12: 873-880

Becker M, Kramann R, Franke A, Breithardt OA, Heussen N, Knackstedt C, Stellbrink C, Schauerte P, Kelm M, Hoffmann R. Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography. Eur Heart J 2007;10: 1211-1220

Gold MR, Birgersdotter-Green U, Singh JP, Ellenbogen KA, Yu Y, Meyer TE, Seth M, Tchou PJ. The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy. Eur Heart J 2011;20: 2516-2524

Saba S, Marek J, Schwartzman D, Jain S, Adelstein E, White P, Oyenuga OA, Onishi T, Soman P, Gorcsan J 3rd. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial. Circ Heart Fail 2013;3: 427-434

Leyva F. Cardiac resynchronization therapy guided by cardiovascular magnetic resonance. J Cardiovasc Magn Reason 2010;12.1: 64

Massacesi C, Ceriello L, Maturo F, Porreca A, Appignani M, Di Girolamo E. Cardiac resynchronization therapy with multipoint pacing via quadripolar lead versus traditional biventricular pacing: A systematic review and meta-analysis of clinical studies on hemodynamic, clinical, and prognostic parameters. Heart Rhythm 2021; 2.6: 682-690

Almusaad A, Sweidan R, Alanazi H, Jamiel A, Bokhari F, Al Hebaishi Y, Al Fagih A, Alrawahi N, Al-Mandalawi A, Hashim M, Al Ghamdi B, Amin M, Elmaghawry M, Al Shoaibi N, Sorgente A, Loricchio M, AlMohani G, Al Abri I, Benjamin E, Sudan N, Chami A, Badie N, Sayed M, Hersi A. Long-term reverse remodeling and clinical improvement by MultiPoint Pacing in a randomized, international, Middle Eastern heart failure study. J Interv Card Electrophysiol 2022; 63.2: 399-407

Leyva F, Nisam S, Auricchio A. 20 years of cardiac resynchronization therapy. J Am Coll Cardiol 2014;64.10: 1047-1058

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;10: 1037-1147

Hartupee J, Mann DL. Neurohormonal activation in heart failure with reduced ejection fraction. Nat Rev Cardiol 2017; 14.1: 30-38

Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002; 39.2: 194-201

Spragg DD, Kass DA. Pathobiology of left ventricular dyssynchrony and resynchronization. Prog Cardiovasc Dis 2006; 49.1: 26-41

Akhtar Z, Gallagher MM, Kontogiannis C, Leung LWM, Spartalis M, Jouhra F, Sohal M, Shanmugam N. Progress in Cardiac Resynchronisation Therapy and Optimisation. J Cardiovasc Dev Dis. 2023 17;[10]:428

Nagueh SF. Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications. J Am Coll Cardiol 2008; 51.1: 18-22

Asgar AW, Mack MJ, Stone GW. Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol 2015; 65.12: 1231-1248

Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, Mortensen P, Klein H. The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study. Am J Cardiol 1999; 83.5: 130-135

Zhu H, Zou T, Zhong Y, Yang C, Ren Y, Wang F. Prevention of non-response to cardiac resynchronization therapy: points to remember. Heart Fail Rev. 2020; 25: 269-275

Zhang B, Guo J, Zhang G. Comparison of triple-site ventricular pacing versus conventional cardiac resynchronization therapy in patients with systolic heart failure: A meta-analysis of randomized and observational studies. J Arrhythm 2018;34.1: 55-64

Mehta VS, Elliott MK, Sidhu BS, Gould J, Porter B, Niederer S, Rinaldi CA. Multipoint pacing for cardiac resynchronisation therapy in patients with heart failure: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 202;32.9: 2577-2589

Ryu K, Ghanem RN, Khrestian CM, Matsumoto N, Goldstein RN, Sahadevan J, Dorostkar PC, Waldo AL. Comparative effects of single- and linear triple-site rapid bipolar pacing on atrial activation in canine models. Am J Physiol Heart Circ Physiol 2005;1:H374-84.

Leclercq C, Gadler F, Kranig W, Ellery S, Gras D, Lazarus A, Clémenty J, Boulogne E, Daubert JC; TRIP-HF (Triple Resynchronization In Paced Heart Failure Patients) Study Group. A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure. J Am Coll Cardiol 2008; 51.15: 1455-1462

Ginks MR, Duckett SG, Kapetanakis S, Bostock J, Hamid S, Shetty A, Ma Y, Rhode KS, Carr-White GS, Razavi RS, Rinaldi CA. Multi-site left ventricular pacing as a potential treatment for patients with postero-lateral scar: insights from cardiac magnetic resonance imaging and invasive haemodynamic assessment. Europace.2012;3:373-9

Lenarczyk R, Kowalski O, Sredniawa B, Pruszkowska-Skrzep P, Mazurek M, Jędrzejczyk-Patej E, Woźniak A, Pluta S, Głowacki J, Kalarus Z. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial. J Cardiovasc Electrophysiol 2012;11:1228-36.

Rogers DP, Lambiase PD, Lowe MD, Chow AW. A randomized double-blind crossover trial of triventricular versus biventricular pacing in heart failure. Eur J Heart Fail 2012;14:495-505.

Ellenbogen KA, Auricchio A, Burri H. The evolving state of cardiac resynchronization therapy and conduction system pacing: 25 years of research at EP Europace journal. Europace 2023;25:euad168

Thibault B, Dubuc M, Khairy P, Guerra PG, Macle L, Rivard L, Roy D, Talajic M, Karst E, Ryu K, Paiement P, Farazi TG. Acute haemodynamic comparison of multisite and biventricular pacing with a quadripolar left ventricular lead. Europace 2013;15:984-91.

Rinaldi CA, Kranig W, Leclercq C, Kacet S, Betts T, Bordachar P, Gutleben KJ, Shetty A, Keel A, Ryu K, Farazi TG, Simon M, Naqvi TZ. Acute effects of multisite left ventricular pacing on mechanical dyssynchrony in patients receiving cardiac resynchronization therapy. J Card Fail. 2013;19:731-8

Rinaldi CA, Leclercq C, Kranig W, Kacet S, Betts T, Bordachar P, Gutleben KJ, Shetty A, Donal E, Keel A, Ryu K, Farazi TG, Simon M, Naqvi TZ. Improvement in acute contractility and hemodynamics with multipoint pacing via a left ventricular quadripolar pacing lead. J Interv Card Electrophysiol. 2014;40:75-80

Pappone C, Ćalović Ž, Vicedomini G, Cuko A, McSpadden LC, Ryu K, Romano E, Saviano M, Baldi M, Pappone A, Ciaccio C, Giannelli L, Ionescu B, Petretta A, Vitale R, Fundaliotis A, Tavazzi L, Santinelli V. Multipoint left ventricular pacing improves acute hemodynamic response assessed with pressure-volume loops in cardiac resynchronization therapy patients. Heart Rhythm. 2014;11:394-401

Pappone C, Ćalović Ž, Vicedomini G, Cuko A, McSpadden LC, Ryu K, Jordan CD, Romano E, Baldi M, Saviano M, Pappone A, Vitale R, Catalano C, Ciaccio C, Giannelli L, Ionescu B, Petretta A, Fragakis N, Fundaliotis A, Tavazzi L, Santinelli V. Improving cardiac resynchronization therapy response with multipoint left ventricular pacing: Twelve-month follow-up study. Heart Rhythm. 2015;12:1250-8

Shetty AK, Sohal M, Chen Z, Ginks MR, Bostock J, Amraoui S, Ryu K, Rosenberg SP, Niederer SA, Gill J, Carr-White G, Razavi R, Rinaldi CA. A comparison of left ventricular endocardial, multisite, and multipolar epicardial cardiac resynchronization: an acute haemodynamic and electroanatomical study. Europace. 2014;16:873-9

Zanon F, Baracca E, Pastore G, Marcantoni L, Fraccaro C, Lanza D, Picariello C, Aggio S, Roncon L, Dell'Avvocata F, Rigatelli G, Pacetta D, Noventa F, Prinzen FW. Multipoint pacing by a left ventricular quadripolar lead improves the acute hemodynamic response to CRT compared with conventional biventricular pacing at any site. Heart Rhythm 2015;12:975-81

Zanon F, Marcantoni L, Baracca E, Pastore G, Lanza D, Fraccaro C, Picariello C, Conte L, Aggio S, Roncon L, Pacetta D, Badie N, Noventa F, Prinzen FW. Optimization of left ventricular pacing site plus multipoint pacing improves remodeling and clinical response to cardiac resynchronization therapy at 1 year. Heart Rhythm 2016;13(8):1644-51

Menardi E, Ballari GP, Goletto C, Rossetti G, Vado A. Characterization of ventricular activation pattern and acute hemodynamics during multipoint left ventricular pacing. Heart Rhythm 2015;12:1762-9

Bencardino G, Di Monaco A, Russo E, Colizzi C, Perna F, Pelargonio G, Narducci ML, Gabrielli FA, Lanza GA, Rebuzzi AG, Crea F. Outcome of Patients Treated by Cardiac Resynchronization Therapy Using a Quadripolar Left Ventricular Lead. Circ J 2016;(16)613-8.

Osca J, Alonso P, Cano O, Andrés A, Miro V, Tello MJ, Olagüe J, Martínez L, Salvador A. The use of multisite left ventricular pacing via quadripolar lead improves acute haemodynamics and mechanical dyssynchrony assessed by radial strain speckle tracking: initial results. Europace 2016;18:560-7

Forleo GB, Di Biase L, Bharmi R, Dalal N, Panattoni G, Pollastrelli A, Tesauro M, Santini L, Natale A, Romeo F. Hospitalization rates and associated cost analysis of cardiac resynchronization therapy with an implantable defibrillator and quadripolar vs. bipolar left ventricular leads: a comparative effectiveness study. Europace 2015 ;17(1):101-7.

Forleo GB, Santini L, Giammaria M, Potenza D, Curnis A, Calabrese V, Ricciardi D, D'agostino C, Notarstefano P, Ribatti V, Morani G, Mantica M, Di Biase L, Bertaglia E, Calò L, Zanon F. Multipoint pacing via a quadripolar left-ventricular lead: preliminary results from the Italian registry on multipoint left-ventricular pacing in cardiac resynchronization therapy (IRON-MPP) Europace 2017;19(7):1170-1177

Niazi I, Baker J 2nd, Corbisiero R, Love C, Martin D, Sheppard R, Worley SJ, Varma N, Lee K, Tomassoni G; MPP Investigators. Safety and Efficacy of Multipoint Pacing in Cardiac Resynchronization Therapy: The MultiPoint Pacing Trial. JACC Clin Electrophysio 2017;26:1510-1518.

Gu M, Jin H, Hua W, Fan XH, Ding LG, Wang J, Niu HX, Cai C, Zhang S. Repetitive optimizing left ventricular pacing configurations with quadripolar leads improves response to cardiac resynchronization therapy: A single-center randomized clinical trial. Medicine 2017;96:e8066

Behar JM, Bostock J, Zhu Li AP, Chin HM, Jubb S, Lent E, Gamble J, Foley PW, Betts TR, Rinaldi CA, Herring N. Cardiac Resynchronization Therapy Delivered Via a Multipolar Left Ventricular Lead is Associated with Reduced Mortality and Elimination of Phrenic Nerve Stimulation: Long-Term Follow-Up from a Multicenter Registry. J Cardiovasc Electrophysiol 2015;26:540-6

Behar JM, Chin HM, Fearn S, Ormerod JO, Gamble J, Foley PW, Bostock J, Claridge S, Jackson T, Sohal M, Antoniadis AP, Razavi R, Betts TR, Herring N, Rinaldi CA. Cost-Effectiveness Analysis of Quadripolar Versus Bipolar Left Ventricular Leads for Cardiac Resynchronization Defibrillator Therapy in a Large, Multicenter UK Registry. JACC Clin Electrophysiol 2017;3:107-116

Turakhia MP, Cao M, Fischer A, Nabutovsky Y, Sloman LS, Dalal N, Gold MR. Reduced Mortality Associated With Quadripolar Compared to Bipolar Left Ventricular Leads in Cardiac Resynchronization Therapy. JACC Clin Electrophysiol 2016;2:426-433.

Leyva F, Zegard A, Qiu T, Acquaye E, Ferrante G, Walton J, Marshall H. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization. J Am Heart Assoc 2017 ;6:e007026

Leshem E, Suleiman M, Laish-Farkash A, Haim M, Geist M, Luria D, Glikson M, Goldenberg I, Michowitz Y; Israeli Working Group of Pacing and Electrophysiology. Impact of quadripolar LV leads on heart failure hospitalization rates among patients implanted with CRT-D: data from the Israeli ICD Registry. J Interv Card Electrophysiol 2018;51:5-12.

Ciconte G, Ćalović Ž, Vicedomini G, Cuko A, McSpadden LC, Jiang C, Ryu K, Caporaso I, Stutz R, Winter D, Saviano M, Vitale R, Conti M, Santinelli V, Pappone C. Multipoint pacing improves peripheral hemodynamic response: Noninvasive assessment using radial artery tonometry. Pacing Clin Electrophysiol 2018;41:106-113

Lercher P, Lunati M, Rordorf R, Landolina M, Badie N, Qu F, Casset C, Ryu K, Ghio S, Singh JP, Leclercq C. Long-term reverse remodeling by cardiac resynchronization therapy with MultiPoint Pacing: A feasibility study of noninvasive hemodynamics-guided device programming. Heart Rhythm 2018;15:1766-1774

Leclercq C, Burri H, Curnis A, Delnoy PP, Rinaldi CA, Sperzel J, Lee K, Calò L, Vicentini A, Concha JF, Thibault B. Cardiac resynchronization therapy non-responder to responder conversion rate in the more response to cardiac resynchronization therapy with MultiPoint Pacing (MORE-CRT MPP) study: results from Phase I. Eur Heart J 2019 ;40:2979-2987

Leclercq C, Burri H, Delnoy PP, Rinaldi CA, Sperzel J, Calò L, Concha JF, Fusco A, Al Samadi F, Lee K, Thibault B. Cardiac resynchronization therapy non-responder to responder conversion rate in the MORE-CRT MPP trial Europace. 2023 ;25:euad294.

Hu, F., Chen, B., Guo, Y., Kang, Y., Yuan, Y., & Lin, Z. Comparison of the effects of multipoint pacing and conventional biventricular pacing on cardiac synchrony and function: a systematic review and meta-analysis. J Interv Card Electrophysiol 2018 ;53: 299-310.

Chung MK, Patton KK, Lau CP, Dal Forno ARJ, Al-Khatib SM, Arora V, Birgersdotter-Green UM, Cha YM, Chung EH, Cronin EM, Curtis AB, Cygankiewicz I, Dandamudi G, Dubin AM, Ensch DP, Glotzer TV, Gold MR, Goldberger ZD, Gopinathannair R, Gorodeski EZ, Gutierrez A, Guzman JC, Huang W, Imrey PB, Indik JH, Karim S, Karpawich PP, Khaykin Y, Kiehl EL, Kron J, Kutyifa V, Link MS, Marine JE, Mullens W, Park SJ, Parkash R, Patete MF, Pathak RK, Perona CA, Rickard J, Schoenfeld MH, Seow SC, Shen WK, Shoda M, Singh JP, Slotwiner DJ, Sridhar ARM, Srivatsa UN, Stecker EC, Tanawuttiwat T, Tang WHW, Tapias CA, Tracy CM, Upadhyay GA, Varma N, Vernooy K, Vijayaraman P, Worsnick SA, Zareba W, Zeitler EP. 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure. Heart Rhythm 2023 ;20:e17-e91

Antoniou CK, Xydis P, Konstantinou K, Magkas N, Manolakou P, Dilaveris P, Chrysohoou C, Gatzoulis KA, Tsioufis C. Multipoint left ventricular pacing as an addition to cardiac resynchronization therapy: a bridge to the holy grail? Am J Cardiovasc Dis 2021 ;1:429-440

van Everdingen WM, Zweerink A, Salden OAE, Cramer MJ, Doevendans PA, Engels EB, van Rossum AC, Prinzen FW, Vernooy K, Allaart CP, Meine M. Pressure-Volume Loop Analysis of Multipoint Pacing With a Quadripolar Left Ventricular Lead in Cardiac Resynchronization Therapy. JACC Clin Electrophysiol 2018;4:881-889

BORGQUIST, Rasmus. One Size Doesn't Fit All: A Closer Look at the Effects of Multipoint Pacing in Cardiac Resynchronization Therapy. JAC 2018; 4.7: 890-892

Okada JI, Washio T, Nakagawa M, Watanabe M, Kadooka Y, Kariya T, Yamashita H, Yamada Y, Momomura SI, Nagai R, Hisada T, Sugiura S. Multi-scale, tailor-made heart simulation can predict the effect of cardiac resynchronization therapy. J Mol Cell Cardiol 2017;108:17-23

Sohal M, Shetty A, Niederer S, Lee A, Chen Z, Jackson T, Behar JM, Claridge S, Bostock J, Hyde E, Razavi R, Prinzen F, Rinaldi CA. Mechanistic insights into the benefits of multisite pacing in cardiac resynchronization therapy: The importance of electrical substrate and rate of left ventricular activation. Heart Rhythm 2015;12:2449-57

Engels EB, Vis A, van Rees BD, Marcantoni L, Zanon F, Vernooy K, Prinzen FW. Improved acute haemodynamic response to cardiac resynchronization therapy using multipoint pacing cannot solely be explained by better resynchronization. J Electrocardiol 2018 ;51:S61-S66

AURICCHIO, Angelo; PRINZEN, Frits W. Enhancing response in the cardiac resynchronization therapy patient: the 3B perspective—bench, bits, and bedside. JACC 2017;3.11: 1203-1219.‏

Rinaldi CA, Burri H, Thibault B, Curnis A, Rao A, Gras D, Sperzel J, Singh JP, Biffi M, Bordachar P, Leclercq C. A review of multisite pacing to achieve cardiac resynchronization therapy. Europace 2015;17:7-17

Schiedat F, Schöne D, Aweimer A, Bösche L, Ewers A, Gotzmann M, Patsalis PC, Mügge A, Kloppe A. Multipoint left ventricular pacing with large anatomical separation improves reverse remodeling and response to cardiac resynchronization therapy in responders and non-responders to conventional biventricular pacing. Clin Res Cardiol 2020;109:183-193

, Corbisiero R, Mathew A, Bickert C, Muller D. Multipoint Pacing with Fusion-optimized Cardiac Resynchronization Therapy: Using It All to Narrow QRS Duration. J Innov Card Rhythm Manag. 2021;12:4355-4362

Ciconte G, Ćalović Ž, McSpadden LC, Ryu K, Mangual J, Caporaso I, Baldi M, Saviano M, Cuko A, Vitale R, Conti M, Giannelli L, Vicedomini G, Santinelli V, Pappone C. Multipoint left ventricular pacing improves response to cardiac resynchronization therapy with and without pressure-volume loop optimization: comparison of the long-term efficacy of two different programming strategies. J Interv Card Electrophysiol 2019:54:141-149

Zhang, C., Liu, H. X., Deng, X. Q., Tong, L., Wang, H., Wang, Y. F., ... & Cai, L. Delay optimization of multipoint pacing increases the cardiac index and narrows the QRS width. Journal of Electrocardiology 2020;60: 114-117.‏

Downloads

Published

2024-11-05

How to Cite

Almusaad, A., Alsalem, A. B., AlTaweel, M., AlMukhaylid, S., AlRasheed, M., AlHebaishi, Y., & Alanazi, H. (2024). Advancing Heart Failure Treatment: The Role of Multipoint Pacing in Cardiac Resynchronization Therapy. International Journal of Clinical Science and Medical Research, 4(11), 388–400. https://doi.org/10.55677/IJCSMR/V4I11-02/2024